TW201428288A - System and method for determining hematocrit insensitive glucose concentration - Google Patents

Abstract

Described are methods and systems to apply a plurality of test voltages to the test strip and measure at least a current transient output resulting from an electrochemical reaction in a test chamber of the test strip so that a glucose concentration can be determined that are generally insensitive to other substances in the body fluid sample that could affect the precision and accuracy of the glucose concentration.

Description

System and method for determining glucose concentration insensitive to blood volume ratio (2)

The present disclosure relates to a system and method for determining glucose concentration that is insensitive to blood volume ratio.

This patent application claims priority to U.S. Patent Application Serial No. 13/630,334 (Attorney Docket No. CIL5031USNP), filed on Sep. 28, 2012, which is incorporated herein by reference. The application of the prior application is incorporated herein by reference in its entirety as if it is incorporated herein.

For today's society, analyte detection in physiological fluids such as blood or blood-derived products has an increasing importance. Analyte detection assays are used in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play an important role in the diagnosis and management of various conditions. Analytes of interest include glucose, cholesterol, and the like for diabetes management. In response to the growing importance of this analyte detection, various analyte detection protocols and devices have been developed for both clinical and home use.

One type of method for analyte detection is the electrochemical method. In such a method, an aqueous liquid sample is placed in a sample receiving chamber in an electrochemical cell that includes two electrodes, such as a counter and a working electrode. The analyte is allowed to react with the redox reagent to form a quantity of oxidizable (or reducible) material, the amount of which is due to the analyte concentration. The amount of oxidizable (or reducible) species present is then electrochemically estimated and correlated with the amount of analyte present in the initial sample.

Such systems are susceptible to various types of inefficiencies and/or errors. For example, blood volume ratio or other substances may affect the outcome of the method.

I have devised various techniques to allow a biosensor system or at least some components of the biosensor system to obtain accurate and accurate blood glucose concentrations from fluid samples that are typically intrinsically insensitive, such as blood volume ratio or any other Factors affecting electrochemical reactions in the determination of blood glucose concentrations.

In one aspect, a method of determining blood glucose concentration using a glucose measurement system is provided. The system includes a biosensor with a biosensor analyzer. The test meter has a microcontroller configured to apply a plurality of test voltages to the test strip and measure at least one transient current output, the transient current output being an electrochemical reaction in the test chamber of the test strip Produced. The method can be implemented by inserting the test strip into the strip connector of the test meter to connect at least two electrodes of the test chamber coupled to the test strip to the strip measuring circuit; Initiating a test procedure, wherein the initiating comprises: applying a first voltage of approximately ground potential to the test chamber for a first period; applying a second voltage to the test chamber for a second period after the first period Changing the second voltage to a third voltage different from the second voltage for a third period after the second period; switching the third voltage to a different value from the third voltage after the third period The fourth voltage continues for a fourth period; after the fourth period, the fourth voltage is converted to a fifth voltage different from the fourth voltage for a fifth period; after the fifth period, the fifth voltage is modified to be different The sixth voltage of the fifth voltage continues for the sixth period; in the sixth period And thereafter changing the sixth voltage to a seventh voltage different from the sixth voltage for a seventh period; measuring at least one of: coming from the first time interval proximate to the second and third periods a first transient current output of the test chamber; a second transient current output during a second time interval proximate to the fifth period; a third transient current output during a third time interval proximate the sixth period a fourth transient current output during a fourth time interval proximate to the sixth and seventh periods; a fifth transient current output during a fifth time interval proximate to the seventh period; and in proximity to the seventh a sixth transient current output during a sixth time interval of the period; and calculating a blood glucose of the sample from at least one of the first, second, third, fourth, fifth, and sixth transient current outputs concentration.

In another aspect, a method of determining blood glucose concentration using a glucose measurement system. The system includes test strips and test gauges. The analyzer has a microcontroller configured to apply a plurality of test voltages to the test strip and to measure at least one transient current output, the transient current output being electrochemicalized in the test chamber of the test strip Learn from the reaction. The method can be implemented by connecting at least two electrodes of a test chamber coupled to the biosensor to a measurement circuit; starting a test procedure after placing the sample, wherein the initiation comprises: applying an approximation a voltage potential of zero to the test chamber for a first period; after the first period, driving a plurality of voltages to the test chamber during a plurality of periods, wherein a voltage of about 1 millivolt for a period of time is in polarity The other voltage in the other period after the one period is reversed such that a change in polarity produces a plurality of transitions in the current output transient of the test chamber; measuring the magnitude of the transient current output, wherein at least two currents The size is close to a transition of each transient current caused by a change in polarity in the plurality of voltages; and the blood glucose concentration of the sample is calculated from the magnitude of the transient current in the measuring step.

In yet a further aspect, a blood glucose measurement system comprising at least one analyte test strip and an analyte test meter is provided. The at least one analyte test strip includes The substrate on which the reagent is disposed and at least two electrodes adjacent to the reagent in the test chamber. The analyte test meter includes a strip connector, a power source, and a microcontroller configured to connect the two electrodes. The microcontroller is electrically coupled to the strip connector and the power source such that when the test strip is inserted into the strip connector and the blood sample is placed to chemically convert blood glucose in the blood sample At least one of the first, second, third, fourth, fifth or sixth transient current outputs from the test chamber from the test chamber by the microcontroller when testing the chamber The blood glucose concentration of the blood sample is measured.

Further, for these aspects, the following features may be used in combination with these previously disclosed aspects or with each other to implement various modifications of the invention. For example, the plurality of voltages can include two equal-sized but opposite-polarity voltages; and the measuring can include summing the transient current output of the transient current decay during a time interval near the transient current decay; the plurality of periods can Included in the second, third, fourth, fifth, sixth, and seventh periods after the first period; the plurality of voltages may include a polarity opposite to the third, fifth, and seventh voltages and The fourth and sixth voltages are of the same polarity; each of the second to seventh voltages may comprise about 1 millivolt; or the measuring may comprise sampling the transient current for: (a) during the second period a first time interval in the middle of the transition of the output transient current, (b) a second time interval in the fifth period in which the voltage is applied, and (c) a third time interval in the sixth period in which the voltage is applied, ( d) a fourth time interval overlapping the third time interval in the sixth period of applying the voltage, (e) a fifth time interval in the seventh period; and (f) a sixth time in the seventh period interval.

Further, for these aspects, the following features may be used in combination with these previously disclosed aspects or with each other to implement various modifications of the invention. For example, the second voltage may include a voltage having a polarity opposite to the third, fifth, and seventh voltages and having the same polarity as the fourth and sixth voltages; each of the second to seventh voltages may include about 1 Millivolt; this calculation can include the use of equations of the form: Wherein: G represents a blood glucose concentration; I _a may include _a transient current output (or sampled summed) measured during a first time interval near a transition of the output transient current during the second period; _b may include a fifth voltage is applied during a second time interval (or the sampling and summing) the measured output current transient; I _c may include a sixth voltage is applied during the third time interval Measured (or sampled and summed) transient current output; _Id may be included in a fourth time interval that overlaps with the third time interval during a sixth period of applied voltage (or sum of samples) a summed) transient current output; I _e may include a measured (or sampled and summed) transient current output during a fifth time interval in the seventh period; and I _f may be included in the seventh period The measured (or sampled and summed) transient current output during the sixth time interval; x ₁ 1.096e0;x ₂ 7.943e-1; x ₃ 6.409e-2; x ₄ 4.406e0; x ₅ 5.087e-3; x ₆ 3.936e-3; x ₇ 1; x ₈ 3.579e1; x ₉ 1; x ₁₀ 1; x ₁₁ 1; x ₁₂ 1;x ₁₃ 1.

In the foregoing aspects of the present disclosure, the steps of determining, estimating, calculating, computing, deriving, and/or using (possibly incorporating a program) may be performed by an electronic circuit or a processor. These steps can also be implemented as executable instructions stored on a computer readable medium; when executed by a computer, the instructions can perform the steps of any of the methods described above.

In still another aspect of the present disclosure, there are a plurality of computer readable media, each media containing executable instructions that, when executed by a computer, perform the steps of any of the foregoing methods.

In a further aspect of the present disclosure, there are a plurality of devices, such as test or analyte testing devices, each device or meter comprising an electronic circuit configured to perform the steps of any of the foregoing methods Or processor.

These and other embodiments, features and advantages will become apparent to those skilled in the <RTIgt;

164‧‧‧上壁

166‧‧‧The lower wall

202‧‧‧Visual display

210‧‧‧ memory unit

212‧‧‧ processor

700‧‧‧ method

702‧‧‧Steps

704‧‧‧Steps

707‧‧ steps

708‧‧ steps

710‧‧ steps

802‧‧ ‧ upper limit

804‧‧‧ lower limit

902‧‧‧ Upper blood glucose deviation range

902a‧‧‧ upper border

902b‧‧‧ upper border

904‧‧‧ lower deviation

904a‧‧‧ lower border

904b‧‧‧ lower border

BRIEF DESCRIPTION OF THE DRAWINGS The accompanying drawings, which are incorporated in FIG The pattern number indicates the same component).

Figure 1A illustrates a preferred blood glucose measurement system.

FIG. 1B illustrates various components in the test meter of FIG. 1A.

1C illustrates a perspective view of an assembled test strip suitable for use in the systems and methods disclosed herein; FIG. 1D illustrates an exploded perspective view of an unassembled test strip suitable for use in the systems and methods disclosed herein; FIG. 1E illustrates a suitable disclosure herein. 2 is an enlarged perspective view of a proximal portion of a test strip in the system and method; FIG. 2 is a bottom plan view of one embodiment of the test strip disclosed herein; FIG. 3 is a side plan view of the test strip of FIG. 2; FIG. FIG. 4B is a partial side elevational view of the proximal portion of the test strip of FIG. 4A; FIG. 5 is a simplified schematic diagram of a test meter illustrating electrical junctions with portions of the test strip disclosed herein; FIG. A plot of the input potential applied to the biosensor and the current output from the biosensor during the test procedure; Figure 6B illustrates the correlation between current and blood glucose (solid line) and current to blood volume ratio (dashed line) Figure 7 is an exemplary logic flow diagram of the techniques described herein; Figure 8 is a graphical representation of the results of a preliminary attempt to obtain a more accurate blood glucose concentration; Figure 9A illustrates the blood glucose concentration of each measurement. Reference blood The concentration of blood glucose concentration in comparison deviation; when the respective blood glucose concentration measured in FIG 9B illustrates less than 75mg / dL and reference The magnitude of the deviation compared to the blood volume ratio; FIG. 9C illustrates the percentage deviation of the measured blood glucose concentration at or above 75 mg/dL compared to the reference blood volume ratio; FIG. 10 is an exemplary technique compared to the reference value. Performance.

The following detailed description must be read with reference to the drawings in which like elements in the different figures are numbered in the same way. The drawings are not necessarily to scale unless the This detailed description is by way of example, This description is made to enable a person skilled in the art to make and use the invention.

As used in this specification, the term "about" or "approximately" in any numerical or <RTI ID=0.0> </ RTI> </ RTI> </ RTI> means a suitable scale tolerance, and a portion or combination of components can be used for the purpose (as in this specification). The speaker) works. More specifically, "about" or "about" may refer to the range of ±40% of the stated value, for example, "about 90%" may mean a range of values from 81% to 99%. As used herein, "oscillating signal" includes a voltage signal or a current signal that changes the polarity or alternating direction of the current or is multi-directional. The phrase "telephone" or "signal" as used in this document includes any signal in the DC signal, the AC signal or the electromagnetic spectrum. The terms "processor," "microprocessor," or "microcontroller" have the same meaning and are used interchangeably. In addition, as used herein, the terms "patient", "host", "user" and "object" refer to any human or animal object and are not intended to limit these systems and methods to human use, even if The use of the invention in a human patient represents a preferred embodiment. The term "notification" used in this article and its variant representation of the root word can be used A notice provided by a combination of words, sounds, vision or all modes or media communicated with the user.

FIG. 1A depicts a diabetes management system including a test meter 10 and a biosensor in the form of a blood glucose test strip 62. It is worth noting that the test meter (test unit) can be referred to as an analyte measurement and management unit, a blood glucose meter, a test meter, and an analyte measuring device. In an embodiment, the test meter unit can be combined with an insulin delivery device, an additional analyte testing device, and a drug delivery device. The test meter unit can be connected to a remote computer or remote server via a cable or a suitable wireless technology such as GSM, CDMA, Bluetooth, WiFi, and the like.

Referring back to FIG. 1A, the blood glucose meter or test meter unit 10 can include a housing 11, user interface buttons (16, 18, and 20), a display 14 and a strip opening 22. User interface buttons (16, 18, and 20) can be configured to allow input of data, navigation of menus, and execution of commands. The user interface button 18 can be in the form of a two-way toggle switch. The data may include values representative of the analyte concentration, and/or information relating to the individual's daily lifestyle. Information about daily lifestyles can include food intake, drug use, health check events, and general health and personal exercise. The electronic components of the test meter 10 can be disposed on a circuit board 34 that is internal to the housing 11.

FIG. 1B illustrates (in a schematic schematic form) electronic components disposed on a top surface of circuit board 34. On the top surface, the electronic components include a strip connector 22, an operational amplifier circuit 35, a microcontroller 38, a display connector 14a, a non-volatile memory 40, a clock 42 and a first wireless module 46. On the bottom surface, the electronic components can include battery connectors (not shown) and data ports 13. The microcontroller 38 can be electrically coupled to the strip connector 22, the operational amplifier circuit 35, the first wireless module 46, the display 14, the non-volatile memory 40, the clock 42, the battery, the data port 13, and the user interface button ( 16, 18 and 20).

The operational amplifier circuit 35 can include two or more operational amplifiers that are configured to provide a partial potential auto-tuner function and a current measurement function. The potential self-tuning function can refer to applying a test voltage between at least two electrodes of the test strip. The current function can be used to measure the test current produced by the applied test voltage. This current measurement can be performed using a current to voltage converter. Microcontroller 38 may be in the form of a mixed signal microprocessor (MSP), such as Texas Instruments MSP 430. The TI-MSP 430 can be configured to perform a portion of the potentiometer function and current measurement functions as well. In addition, MSP 430 can also include volatile or non-volatile memory. In another embodiment, a number of electronic components can be integrated with the microcontroller into the form of a special application integrated circuit (ASIC).

The strip connector 22 can be configured to form an electrical connection to the test strip. Display connector 14a can be organized to attach to display 14. The display 14 can be in the form of a liquid crystal display for reporting the measured blood glucose level and facilitating the input of lifestyle related information. Display 14 can optionally include a backlight. The data cartridge 13 can accept a suitable connector that attaches the connector to the connecting wire to allow the blood glucose meter 10 to be connected to an external device, such as a personal computer. The data port 13 can be any port that allows data to be transferred, such as serial, USB or parallel port. The clock 42 can be organized to maintain the current time associated with the geographic area in which the user is located, as well as to measure time. The test meter unit can be configured to be electrically connected to a power source, such as a battery.

1C-1E, 2, 3, and 4B illustrate various views of an exemplary test strip 62 suitable for use in the methods and systems described herein. In the exemplary embodiment, a test strip 62 is provided that includes an elongated body extending from the distal end 80 to the proximal end 82 and having sides 56, 58 as illustrated in Figure 1C. As illustrated in FIG. 1D, the test strip 62 further includes a first electrode layer 66, a second electrode layer 64, and a spacer 60 sandwiched between the two electrode layers 64 and 66. The first electrode layer 66 may include a first electrode 66, a first connection track 76, and a first contact pad 67, wherein the first connection track 76 electrically connects the first electrode 66 to the first contact pad 67, such as 1D and 4B. Illustration. Notably, the first electrode 66 is part of the first electrode layer 66, and the first electrode layer 66 is directly below the reagent layer 72, as indicated in Figures 1D and 4B. Similarly, the second electrode layer 64 may include a second electrode 64, a second connection track 78, and a second contact pad 63, wherein the second connection track 78 electrically connects the second electrode 64 with the second contact pad 63, as shown in FIG. 1D. , 2 and 4B are shown. Notably, the second electrode 64 is part of the second electrode layer 64, and the second electrode layer 64 is above the reagent layer 72, as indicated in Figure 4B.

As illustrated, the sample receiving chamber 61 is defined by a first electrode 66, a second electrode 64, and a septum 60 adjacent the distal end 80 of the test strip 62, as illustrated in Figures 1D and 4B. The first electrode 66 and the second electrode 64 may define the bottom and top of the sample receiving chamber 61, respectively, as illustrated in Figure 4B. The slit region 68 of the septum 60 can define the sidewall of the sample receiving chamber 61 together with the upper wall 164 and the lower wall 166, as illustrated in Figure 4B. In one aspect, the sample receiving chamber 61 can include a crucible 70 that provides a sample inlet and/or a discharge port, as illustrated in Figures 1C-1E. For example, one of the crucibles can allow fluid sample to enter, and other crucibles can allow air to flow out.

In an exemplary embodiment, the sample receiving chamber 61 (or test slot or test chamber) can have a small volume. For example, chamber 61 can have a volume ranging from about 0.1 microliters to about 5 microliters, from about 0.2 microliters to about 3 microliters, or preferably from about 0.3 microliters to about 1 microliter. To provide the small sample volume, the cutout 68 may have a range of from about 0.01cm ² to about 0.2cm ² area of about 0.02cm ² to about 0.15cm ^2, or preferably from about 0.03cm ² of about 0.08cm ^2. Furthermore, the first electrode 66 and the second electrode 64 may have a spacing ranging from about 1 micron to about 500 microns, preferably between about 10 microns and about 400 microns, and more preferably between about 40 microns. And between about 200 microns. The relatively close spacing of the electrodes may also allow for a redox cycle to occur where the oxidizing species generated at the first electrode 66 may diffuse to the second electrode 64 to become reduced and subsequently diffuse back to the first electrode 66 to become oxidized again. It will be understood by those of ordinary skill in the art that various such volumes, areas and/or spacings of the electrodes are within the spirit and scope of the present disclosure.

In one embodiment, the first electrode layer 66 and the second electrode layer 64 may be composed of, for example, gold, palladium, carbon, silver, platinum, tin oxide, antimony, indium, or a combination thereof (eg, tin oxide doped with indium) A conductive material formed by materials. Further, the electrodes may be formed by disposing a conductive material on an insulating sheet (not shown) by sputtering, electroless plating or screen printing. In an exemplary embodiment, the first electrode layer 66 and the second electrode layer 64 may be made of sputtered palladium and sputtered gold, respectively. Suitable materials that can be used as the spacer 60 include various insulating materials such as plastics (e.g., PET, PETG, polyimide, polycarbonate, polystyrene), tantalum, ceramics, glass, adhesives, and combinations thereof. In one embodiment, the spacer 60 can be in the form of a double-sided adhesive applied to the opposite side of the polyester sheet, wherein the adhesive can be pressure sensitive or heat activated. Applicant noted that various other materials for the first electrode layer 66, the second electrode layer 64, and/or the spacers 60 are within the spirit and scope of the present disclosure.

Either the first electrode 66 or the second electrode 64 can perform the function of the working electrode, depending on the magnitude and/or polarity of the applied test voltage. The working electrode can measure a limited test current proportional to the concentration of the reduced vehicle. For example, if the current limiting species is a reducing medium (eg, ferrocyanide), the reducing medium can be oxidized at the first electrode 66 as long as the test voltage relative to the second electrode 64 is sufficiently greater than the redox vehicle potential. In this case, the first electrode 66 performs the function of the working electrode and the second electrode 64 performs the function of the counter/reference electrode. The Applicant has noted that the counter/reference electrode can be simply referred to as a reference electrode or a counter electrode. Limited oxidation occurs when all of the reducing medium has been depleted on the surface of the working electrode such that the measured oxidation current is proportional to the flux of the reducing medium diffusing from the bulk solution to the surface of the working electrode. The term "whole solution" means a solution portion that is sufficiently far from the working electrode. The fraction, wherein the reducing vehicle is not in the depletion zone. It should be noted that unless otherwise stated for test strip 62, all subsequent potentials applied by test meter 10 will be stated relative to second electrode 64.

Similarly, if the test voltage is sufficiently less than the potential of the redox mediator, the reducing agent can be oxidized to a limited current at the second electrode 64. In this case, the second electrode 64 performs the function of the working electrode and the first electrode 66 performs the function of the counter/reference electrode.

Initially, the analysis can include introducing a quantity of fluid sample into the sample receiving chamber 61 via the crucible 70. In one aspect, the crucible 70 and/or the sample receiving chamber 61 can be positioned such that capillary action causes the fluid sample to fill the sample receiving chamber 61. The first electrode 66 and/or the second electrode 64 may be coated with a hydrophilic agent to promote capillary action of the sample receiving chamber 61. For example, a thiol-derived reagent having a hydrophilic group such as 2-mercaptoethanesulfonic acid may be applied to the first electrode and/or the second electrode. Additional details of the biosensor and system are illustrated and described in the following U.S. Patent Nos. 6,179,979; No. 6,191,873; No. 6,284,125; No. 64,134,10; No. 6,647,372; No. 6,716,577; No. 6,749,887; No. 6,683,801 , No. 6890421; No. 7045046; No. 7291256; No. 7498132, the entire disclosure of which is incorporated herein by reference.

In the analysis of test strip 62 above, reagent layer 72 may include blood glucose dehydrogenase (GDH) based on PQQ cofactor and ferricyanide. In another embodiment, the PQQ cofactor based enzyme GDH can be replaced with the FAD cofactor based enzyme GDH. When blood or a control solution is administered to the sample reaction chamber 61, blood glucose is _oxidized by GDH _(ox) , and GDH _{(ox) is} converted into GDH _(red) in the process, as shown by chemical conversion T.1 below. It should be noted that GDH _(ox) refers to the oxidation state of GDH, and GDH _(red) refers to the reduced state of GDH.

T.1 D-glucose + GDH _(ox) → gluconic acid + GDH _(red)

Next, GDH _(red) is regenerated back to its active oxidation state by ferricyanide (ie, oxidizing vehicle or Fe(CN) ₆ ^3- ), as shown by chemical conversion T.2 below. In the process of regenerating GDH _(ox) , ferrocyanide (ie, reducing medium or Fe(CN) ₆ ^4- ) is produced by the reaction shown by T.2: T.2 GDH _(red) +2 Fe ( CN) ₆ ^3- →GDH _(ox) +2 Fe(CN) ₆ ^4-

FIG. 5 provides a simplified schematic diagram illustrating the interface of test meter 100 with first contact pads 67a, 67b and second contact pads 63. The second contact pad 63 can be used to establish an electrical connection to the test meter via the U-shaped slit 65, as shown in Figures 1D and 2. In one embodiment, the test meter 100 can include a second electrode connector 101 and first electrode connectors (102a, 102b), a test voltage unit 106, a current measurement unit 107, a processor 212, a memory unit 210, and a visual Display 202 is shown in FIG. The first contact pad 67 can include two bifurcations denoted 67a and 67b. In an exemplary embodiment, the first electrode connectors 102a and 102b are separately connected to the bifurcations 67a and 67b, respectively. The second electrode connector 101 may be connected to the second contact pad 63. Test meter 100 can measure the electrical resistance or electrical continuity between furcations 67a and 67b to determine if test strip 62 is electrically connected to test meter 10.

In one embodiment, test meter 100 can apply a test voltage and/or current between first contact pad 67 and second contact pad 63. Once the test meter 100 recognizes that the test strip 62 has been inserted, the test meter 100 activates and initiates the fluid detection mode. In one embodiment, the fluid detection mode causes test meter 100 to apply a fixed current of about 1 microamperes between first electrode 66 and second electrode 64. Since the test strip 62 is initially dry, the test meter 10 measures a relatively large voltage. When the fluid sample bridges the gap between the first electrode 66 and the second electrode 64 during administration, the test meter 100 reduces the measured measurement voltage below a predetermined threshold to cause the test meter 10 to automatically start. Blood sugar test.

Applicants have determined that in order to obtain accurate and accurate blood glucose concentration values, a waveform or drive voltage must be tailored to produce a stable transient current output from the biosensor. This is especially important because the reproducibility of the points in the transient associated with blood glucose concentration must be as high as possible. At the same time, by providing such transient currents, the Applicant can be allowed to obtain several independent techniques to calculate blood glucose concentration values that are actually insensitive to blood volume ratios in blood samples.

Figure 6A depicts a particular waveform (dashed line labeled "Vt") and the resulting transient current (solid line labeled "I _t ") that is considered suitable for the applicant's purposes and for that particular biosensor. Figure 6B provides insight into the correlation (vertical axis) in transient currents to blood glucose and blood volume ratios. It will be observed that there is usually an area within the current response (i.e., transient) that exhibits different sensitivities and inherent disturbances (here to the blood volume ratio) for the measured analyte (blood sugar). This led me to design a technical derivation. In particular, I have devised at least one technique that allows the use of results from transient blood volume sensitive areas to correct blood glucose results obtained using blood glucose sensitive areas. It will be noted that no point in the transient current is not related to the blood volume ratio, but at the same time gives the maximum blood glucose correlation. Therefore, each technology attempts to artificially produce this situation. The most important idea is to use only the stable point in the transient current output, that is, to select the sampling point as far as possible from the peak. Here, the distance from the peak to the sampling point on the right side of the spike is important because the stability and reproducibility of the sampling point after the sampling point are not related. What I have noticed here is that the time scale of Fig. 6A is the same as the time scale of Fig. 6B (having the same start time at zero), so that the two figures can be compared by superimposing or overlapping Fig. 6B and Fig. 6A.

In designing the appropriate technique, I originally used waveform Vt and equation A to obtain the transient current I _{t of} Figure 6A. Equation A is of the form:

Where "g" represents the blood glucose concentration, and I can be the measured (or sampled and summed) transient current output at a time interval close to the predetermined time during the measurement (eg, about 4.9 relative to the start of the measurement procedure) Up to about 5 seconds); x ₁ ~ 0.427, and x ₂ ~ 25.62.

However, when testing was performed to verify the applicant's first attempt (using Equation A), it was found that, as shown in Figure 8, when there is a low blood volume ratio (20%) and a high blood volume ratio ( At 60%), the blood glucose concentration was greatly affected. Specifically, in Figure 8, samples of 106 different blood glucose concentrations (75 mg/dL or greater and less than 75 mg/dL) were tested in three different hematocrit ratios (20%, 38%, and 60%). S1, S2, S3 are aligned with a reference (or actual) analyte level (eg, blood glucose concentration) using a standard laboratory analyzer such as Yellow Springs Instrument (YSI). The deviation "g" of the blood glucose concentration and the corrected blood glucose concentration are determined using the equation of the following form: Bias _abs = G _{calculation -} G _reference equation B.

G- _{reference for} blood glucose less than 75 mg/dL with a deviation target of 15 mg/dL or 20%

The G _{reference for} blood glucose greater than or equal to 75 mg/dL has a deviation target of 15 mg/dL or 10% where: Bias _abs is the absolute deviation, Bias _% is the percentage deviation, G is _calculated as the uncorrected or corrected blood glucose concentration "g" and G is _{referred to} as the reference blood glucose concentration.

Referring back to Figure 8, it can be seen that it is believed that the blood glucose concentration at 20% and 60% of the blood volume ratio is severely affected by the presence of the blood volume ratio, resulting in sample S1 (at 20% blood volume ratio) and in the test. The measurement in sample S3 (in 60% hematocrit) is outside the preferred upper limit 802 and lower limit 804. While the performance of this preliminary technique may be sufficient, however, it is believed that the initial technique of Equation A may not provide the use of a sample containing a very low (eg, 20%) or very high (eg, 60%) hematocrit. Required performance.

However, I was able to devise various techniques that allow the system to overcome this undesirable performance with the initial techniques of Equation A. In particular, referring to Figure 7, a method 700 of determining blood glucose concentration using the biosensor of Figure 1 will now be described. At step 702, the method can begin with the user inserting the test strip into the strip connector of the test meter to connect at least two electrodes of the test chamber coupled to the test strip to the strip measurement circuit. At step 704, the user places an appropriate sample (eg, physiological fluid, blood, or control solution) into the test chamber to initiate the test procedure at step 706 after placing the sample. Step 706 (see FIG. 6A) comprises a number of sub-steps involved testing procedure, e.g. zero potential V1 is applied to the test chamber for a first period t _1; t ₁ after the first period, during a plurality of (in FIG. 6A Driving a plurality of voltages (eg, V2, V3, V4, V5, V6, and V7) into the test chamber for t ₂ , t ₃ , t ₄ , t ₅ , t _{6 ,} and t ₇ ) for a period of time (eg, in t ₂₎ from about 1 millivolt (e.g., V2 in FIG. 6A) FIG. 6A in the period after the polarity of the other (e.g., FIG. 6A t ₂₎ in which a period (e.g., t ₃₎ another voltage (V3 e.g. FIG. 6A) opposite, so that the change in polarity produced in the transition (e.g., I _a) at the output of transient current of the testing chamber. At step 708, it may be performed in parallel or simultaneously with the sub-steps of step 706, such as measuring the magnitude of the transient current output It of each transition of the transient current caused by a change in polarity in the plurality of voltages (eg, Figure 6A) The current magnitude I _e of the time interval Δ5 in the attenuation of I _a , I _b , I _c , I _c and I _e ) or close to the transient current It. Although it is preferred to sample the current at a particular point in time, the magnitude of the current is actually a very short time interval during the transition of the transient current I _t (eg, Δ1...△ in Figure 6A). 4) and measured at a predetermined time point on the decay of the transient current I _t for a predetermined time interval Δ5. In a preferred embodiment, the time intervals Δ1...Δ4 may generally have the same sampling time interval. Alternatively, the sampling time intervals Δ1...Δ5 may have different sampling time intervals. As can be seen in Figure 6A, the second, fourth or sixth period is about 1⁄2 second and the third, fifth or seventh period is about 1 second. In other words, the time interval of each period t ₁ , t ₂ , t ₃ , t ₄ , t ₅ , t ₆ and t ₇ may be a different period.

At step 710, operation is performed by calculating the blood glucose concentration of the sample from the value of the transient current I _t of the measurement step (I _a , I _b , I _c , I _{c ,} and I _{e in} Fig. 6A ). For example, Equation 1 of the following form can be used for blood glucose calculations: Where: G represents the blood glucose concentration of the sample being tested; I _a may be the measured (or sampled and summed) transient in the first time interval near the transition of the output transient current during the second period Current output; I _b may be a measured (or sampled and summed) transient current output in a second time interval during a fifth period of application of the voltage; I _c may be the sixth period during which the voltage is applied The measured (or sampled and summed) transient current output in three time intervals; _Id may be measured in a fourth time interval that overlaps the third time interval during the sixth period of application of the voltage ( Or sampled and summed) transient current output; I _e may be the measured (or sampled and summed) transient current output during the fifth time period in the fifth period; and I _f may be The measured (or sampled and summed) transient current output during the sixth time interval in the seventh period; x ₁ 1.096e0;x ₂ 7.943e-1; x ₃ 6.409e-2; x ₄ 4.406e0; x ₅ 5.087e-3; x ₆ 3.936e-3; x ₇ 1; x ₈ 3.579e1; x ₉ 1; x ₁₀ 1; x ₁₁ 1; x ₁₂ 1;x ₁₃ 1.

It is worth noting here that the multiple voltages V1...V _{N in} Figure 6A (where N 2, 3, 4...n) (illustrated in dashed lines) may include two voltages of equal magnitude (eg, 1 millivolt) but opposite in polarity. Additionally, the duration of the plurality of individual voltages may include the second, third, fourth, fifth, sixth, and seventh periods after the first period, and each period is the same or different, depending on the biological sense Operating parameters of the detector system. In the measurement or sampling of the transient current output I _t (solid line) at each time point, the transient current output measured at each time point may be the sum of the currents at each time point. For example, the first transient current output (solid line) I _a may be the sum of transient current outputs from about 0.8 seconds to about 1.1 seconds and preferably from about 0.9 seconds to about 1 second from the blood glucose measurement procedure; The second transient current output I _b may be a sum of transient current outputs from about 2.7 seconds to about 2.9 seconds and preferably from about 2.75 seconds to about 2.9 seconds from the blood glucose measurement procedure; the third transient current output I _c It may be a sum of transient current outputs from about 3.5 seconds to about 3.9 seconds and preferably from about 3.6 seconds to about 3.9 seconds from the blood glucose measurement procedure; the fourth transient current output _Id may be from the blood glucose measurement procedure The sum of transient current outputs starting from about 3.6 seconds to about 4.1 seconds and preferably from about 3.7 seconds to about 4 seconds; the fifth transient current output I _e can be from about 4.1 seconds to about from the blood glucose measurement procedure. 4.5 seconds and preferably it is the sum of the transient current output from about 4.3 seconds to about 4.4 seconds; and a sixth output transient current I _f may be from about 4.3 seconds to about 4.7 seconds and preferably from about 4.4 seconds to about The sum of the 4.6 seconds of transient current output. It is preferred to produce the most accurate results with the sum of the transient current outputs. In addition, the sum will use a sampling frequency of about 20 Hz such that a 5 second measurement yields 100 current samples called transient currents, illustrated here in Figure 6A.

Although step 706 in Figure 7 has been previously described, other variations may also be part of this step. For example, other sub-steps can be used as part of this main step 706 to accomplish the purpose of step 706. In particular, the sub-steps may include applying a first voltage V1 (shown as a dashed line) approximately at ground potential to the test chamber for a first period t ₁ (FIG. 6A) to provide a time delay, which is believed to be The electrochemical reaction can be started. The next step may involve sub V2 to the test chamber for a second period of applying a second voltage during a first period t ₂ after _{t. 1} (FIG. 6A); a second period t ₂ after the change to the second voltage V2 and the second The third voltage V3 having a different voltage V2 continues for the third period t ₃ ; after the third period, the third voltage V3 is switched to the fourth voltage V4 different from the third voltage for the fourth period t ₄ ; during the fourth period After t ₄ , the fourth voltage V4 is converted to the fifth voltage V5 different from the fourth voltage V4 for the fifth period t ₅ ; after the fifth period t ₅ , the fifth voltage V5 is modified to be different from the fifth voltage The six voltage V6 continues for the sixth period t ₆ ; after the sixth period, the sixth voltage V6 is changed to the seventh voltage V7 different from the sixth voltage V6 for the seventh period t ₇ . Measuring the transient current output performed in the form of a transient (I _t in FIG. 6A) in step may be performed in parallel with steps 706,708, system.

Step 706 includes substeps, for example, measuring at least one of: (a) a first transient current output from the test chamber during a first time interval Δ1 proximate to the second and third periods (I _a (b) a second transient current output ( _Ib ) during a second time interval Δ2 proximate to the fourth and fifth periods; (c) a third time interval Δ3 near the sixth period a third transient current output (I _c ) during: (d) a fourth transient current output (I _d ) during a fourth time interval Δ4 proximate to the sixth period, wherein the fourth time interval and the a third time interval overlap; (e) a fifth transient current output (I _e ) during a fifth time interval intermediate the intermediate time interval of the seventh period; a fifth time interval intermediate the seventh period The sixth transient current output (I _f ) during the time interval. It is worth noting here that each time interval Δ1...Δ4 can include a very short time (eg 10 milliseconds or less) during which the transient current changes very rapidly to show the transient Transition. For example, the first transient current output can be a sum of transient current outputs starting from about 0.8 seconds to about 1.1 seconds and preferably from about 0.9 seconds to about 1 second relative to the test program voltage V1; the second transient current The output may be the sum of transient current outputs starting from about 2.3 seconds to about 2.6 seconds and preferably from about 2.4 seconds to about 2.5 seconds with respect to the test program voltage; the third transient current output may be relative to the test program voltage The sum of transient current outputs starting from about 3.3 seconds to about 3.6 seconds and preferably from about 3.4 seconds to about 3.5 seconds; the fourth transient current output can be from about 3.8 seconds to about 4.1 relative to the test program voltage. Seconds and preferably is the sum of transient current outputs from about 3.9 seconds to about 4 seconds; the fifth transient current output can be from about 4.8 seconds to about 5.1 seconds and preferably from about 4.9 relative to the test program voltage. The sum of the transient current outputs from seconds to about 5 seconds.

Step 710 involves calculating the blood glucose concentration of the sample. Applicants have noted that such calculations can be used as shown in Equation 1 above. The results of step 710 can be signaled to the user regarding the management of blood glucose.

The techniques described herein are also verified by determining the deviation or error between the calculated and referenced blood glucose results, which are illustrated herein in Figures 9A-9C and Figure 10. Each of Figures 9A-9C and Figure 10 will be discussed individually below.

It should be noted that the present invention is not limited to one technique or one feature described herein, but that all or some of the techniques (or features) may be combined with any suitable permutation as long as each of the permutations exerts its intent. The function of allowing blood glucose to be measured and does not actually affect the physical properties of the sample (eg, blood volume ratio).

Referring to Figure 9A, I note that the bias study of this figure is based on an exemplary Equation 1 to derive approximately 10,520 samples. As can be seen in Figure 9A, for each selected reference blood glucose data (e.g., 0 mg/dL to 600 mg/dL), there is generally a high percentage of samples within the upper blood glucose deviation range 902 and the lower deviation 904 (these are respectively The blood glucose concentration is less than ±75 mg/dL for less than 75 mg/dL and ±10% for blood glucose concentration equal to or greater than 75 mg/dL. The correlation coefficient R of Figure 9A is about 99.4% for blood glucose and about 6.6% for blood volume ratio, thus demonstrating that the blood glucose concentration determined by my exemplary technique is substantially unaffected by changes in blood volume ratio in the blood.

Referring to Figure 9B, when the blood glucose concentration is lower than 75 mg/dL, the deviation (in mg/dL) of the blood glucose result G from my technique in the range of 20% to 60% of the reference blood volume ratio is compared (relative to the reference) The YSI result) is generally between the upper boundary 902a and the lower boundary 904a. For 75mg/dL in Figure 9C Or above the blood glucose concentration, comparing the blood volume ratio (from 20% to 60%) from my technique, the percentage deviation (in %) of the blood glucose result G (relative to the reference YSI result), which is generally Between the upper boundary 902b and the lower boundary 904b of the deviation limit.

Figure 10 illustrates independent clinical data demonstrating the transferability of my invention to actual living conditions. This data was taken from 116 diabetes contributors in a clinical setting. The blood glucose concentration G has been calculated based on the downloaded current trace using the coefficient x _1-13 derived from the laboratory data. No error coding or capture was taken. In Fig. 9, for the blood glucose result, about 98.7% of the blood glucose results were in the "A" and about 1.3% of the blood glucose results were in the "B". As can be seen from Figures 9A-C and Figure 10, the results from my technique show greater accuracy and do not require temperature or blood volume ratio correction. Thus, as implemented, our technology provides a technical contribution in that blood glucose measurements can be obtained with minimal interference in the blood volume ratio in the blood.

The present invention has been described by way of specific variations and illustrations, and those skilled in the art can understand that the invention is not limited to the described variations or figures. In addition, where the above methods and steps are directed to specific events occurring in a certain order, those skilled in the art can understand the order in which certain steps can be modified and such modifications are in accordance with variations of the invention. In addition, when practicable, it can be performed collectively in parallel programs, and some of the steps are performed successively as described above. Accordingly, this patent is intended to cover such modifications and equivalents

700‧‧‧ method

702‧‧‧Steps

704‧‧‧Steps

707‧‧ steps

708‧‧ steps

710‧‧ steps

Claims (18)

A method for determining blood glucose concentration using a blood glucose measuring system, the system comprising a test strip and a test meter having a microcontroller configured to apply a plurality of test voltages to the test strip And measuring at least one transient current output generated by an electrochemical reaction in one of the test strips of the test strip, the method comprising the steps of: inserting the test strip into one of the test strips a connector for connecting at least two electrodes of the test chamber coupled to the test strip to a measuring circuit; starting a test procedure after placing a sample, wherein the initiating comprises the step of: applying approximately a first voltage of the ground potential to the test chamber for a first period; applying a second voltage to the test chamber for a second period after the first period; and the second period after the second period Changing a voltage to a third voltage different from the second voltage for a third period; after the third period, switching the third voltage to a fourth voltage different from the third voltage for one a fourth period; after the fourth period, converting the fourth voltage to a fifth voltage different from the fourth voltage for a fifth period; after the fifth period, modifying the fifth voltage to be different from the fourth period a sixth voltage of the five voltages continues for a sixth period; after the sixth period, the sixth voltage is changed to a seventh voltage different from the sixth voltage for a seventh period; at least one of the following is measured a first transient current output from the test chamber during a first time interval proximate to the second and third periods; a second transient current output during a second time interval proximate to the fifth period; a third transient current output during a third time interval proximate the sixth period; approaching the sixth sum a fourth transient current output during a fourth time interval of the seventh period; a fifth transient current output during a fifth time interval proximate to the seventh period; a first in the seventh period a sixth transient current output during a six time interval; and calculating a blood glucose concentration of the sample from at least one of the first, second, third, fourth, fifth, and sixth transient current outputs . The method of claim 1, wherein the second voltage comprises a voltage that is opposite in polarity to the third, fifth, and seventh voltages and is the same as the polarity of the fourth and sixth voltages. The method of claim 1, wherein each of the second to seventh voltages comprises about 1 millivolt. The method of claim 1, wherein the calculation comprises using an equation of the form: Wherein: G represents a blood glucose concentration; I _a comprises a transient current output (or sampled and summed) measured in a first time interval near one of the output transient current transitions during the second period ; I _b comprises (or is sampled and aggregation) in a fifth voltage is applied during the second time interval in a measured output of a transient current; I _c during comprises a sixth voltage is applied to the a transient current output measured in a third time interval (or sampled and summed); _{Id is} included in a fourth time interval that overlaps the third time interval in the sixth period of the applied voltage Measured (or sampled and summed) a transient current output; I _e includes a transient current output (or sampled and summed) measured during a fifth time interval in a seventh period; And I _f includes a transient current output (or sampled and summed) measured during one of the sixth time intervals of the seventh period; x ₁ 1.096e0;x ₂ 7.943e-1; x ₃ 6.409e-2; x ₄ 4.406e0; x ₅ 5.087e-3; x ₆ 3.936e-3; x ₇ 1; x ₈ 3.579e1; x ₉ 1; x ₁₀ 1; x ₁₁ 1; x ₁₂ 1; and x ₁₃ 1. A method for determining blood glucose concentration using a blood glucose measuring system, the system comprising a biosensor having a biosensor analyzer, the analyzer having a a microcontroller configured to apply a plurality of test voltages to the biosensor and to measure at least one transient current output, the transient current output being tested in the chamber by one of the biosensors An electrochemical reaction is generated, the method comprising the steps of: connecting at least two electrodes of the test chamber coupled to the test strip to a biosensor measuring circuit; starting after placing a sample a test procedure, wherein the initiating comprises: applying a voltage potential of about zero to the test chamber for a first period; driving the plurality of voltages to the test chamber during the plurality of periods after the first period, wherein An approximately 1 millivolt voltage for a period of time is opposite in polarity to another voltage during another period after the one period such that a change in polarity produces a plurality of transient current output transients in one of the test chambers Turning; measuring the magnitude of the transient current output transient, wherein at least two current magnitudes are close to a transition of each transient current caused by a polarity change in the plurality of voltages; and from the measurement The magnitude of the transient current in the step calculates the blood glucose concentration of one of the samples. The method of claim 5, wherein the plurality of voltages comprise two equal-sized but opposite-polarity voltages; and the measuring comprises summing the transients during a time interval that is close to one of the transient currents decaying The decaying transient current output of the current. The method of claim 6, wherein the plurality of periods are included in the second, third, fourth, fifth, sixth, and seventh periods after the first period. The method of claim 7, wherein the calculation comprises using one of the following forms: Wherein: G represents a blood glucose concentration; I _a comprises a transient current output (or sampled and summed) measured in a first time interval near one of the output transient current transitions during the second period ; I _b comprises (or is sampled and aggregation) in a fifth voltage is applied during the one second time interval measured output of a transient current; I _c comprises a sixth period of the applied voltage a transient current output measured in a third time interval (or sampled and summed); I _d includes a fourth time interval overlapping the third time interval in the sixth period of the applied voltage Medium-measured (or sampled and summed) transient current output; I _e includes a transient current output measured in one of the fifth time intervals (or sampled and summed) And I _f includes a transient current output (or sampled and summed) measured during a sixth time interval in the seventh period; x ₁ 1.096e0;x ₂ 7.943e-1; x ₃ 6.409e-2; x ₄ 4.406e0; x ₅ 5.087e-3; x ₆ 3.936e-3; x ₇ 1; x ₈ 3.579e1; x ₉ 1; x ₁₀ 1; x ₁₁ 1; x ₁₂ 1; and x ₁₃ 1. The method of claim 7, wherein the plurality of voltages comprise a voltage that is opposite in polarity to the third, fifth, and seventh voltages and is the same as the polarity of the fourth and sixth voltages. The method of claim 7, wherein each of the second to seventh voltages comprises about 1 millivolt. The method of claim 7, wherein the measuring comprises sampling the transient current at: (a) a first time interval in the second period that is close to one of the output transient current transitions, ( b) a second time interval in a fifth period of the applied voltage, (c) a third time interval in a sixth period of the applied voltage, (d) the sixth in the applied voltage a fourth time interval in the period overlapping the third time interval, (e) a fifth time interval in a seventh period; and (f) a sixth time interval in the seventh period. The method of claim 6, wherein the blood glucose concentration from the calculating step is notified. A blood glucose measuring system comprising: at least one analyte test strip comprising: a substrate having a reagent disposed thereon; at least two electrodes adjacent to the reagent in a test chamber; and an analyte meter comprising: a 埠 connector configured to connect the two electrodes; a power source; and a microcontroller electrically coupled to the 埠 connector and the power source such that when the test strip is inserted into the 埠 connector and a blood test When the sample is placed in the test chamber for chemically converting blood glucose in the blood sample, the first, second, and third, from the test chamber by the microcontroller from the applied voltage At least one of the fourth, fifth or sixth transient current output determines a blood glucose concentration of the blood sample. The system of claim 13, wherein the microcontroller calculates the blood glucose concentration using a program of the following form: Where: G indicates a blood glucose concentration; I _a includes a transient current output (or sampled and summed) measured during a first time interval near one of the output transient current transitions during the second period ; I _b comprises (or is sampled and aggregation) in a fifth voltage is applied during the second time interval in a measured output of a transient current; I _c during comprises a sixth voltage is applied to the a transient current output measured in a third time interval (or sampled and summed); _{Id is} included in a fourth time interval that overlaps the third time interval in the sixth period of the applied voltage Measured (or sampled and summed) a transient current output; I _e includes a transient current output (or sampled and summed) measured during a fifth time interval in a seventh period; And I _f includes a transient current output (or sampled and summed) measured during one of the sixth time intervals of the seventh period; x ₁ 1.096e0;x ₂ 7.943e-1; x ₃ 6.409e-2; x ₄ 4.406e0; x ₅ 5.087e-3; x ₆ 3.936e-3; x ₇ 1; x ₈ 3.579e1; x ₉ 1; x ₁₀ 1; x ₁₁ 1; x ₁₂ 1; and x ₁₃ 1. The system of claim 13, wherein the plurality of voltages comprise two equal-sized but opposite-polarity voltages; and the measuring comprises summing the transients during a time interval that is close to one of the transient currents decaying The decaying transient current output of the current. The system of claim 13, wherein the plurality of periods are included in the second, third, fourth, fifth, sixth, and seventh periods after the first period. The system of claim 16, wherein the plurality of voltages comprise a voltage that is opposite in polarity to the third, fifth, and seventh voltages and is the same polarity as the fourth and sixth voltages. The system of claim 16, wherein each of the second to seventh voltages comprises about 1 millivolt.